Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    September 2017
  1. CHO H, Baek MS, Choi JY, Lee SH, et al
    18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.
    Neurology. 2017;89:1170-1178.
    PubMed     Text format     Abstract available


  2. LIM YY, Mormino EC
    APOE genotype and early beta-amyloid accumulation in older adults without dementia.
    Neurology. 2017;89:1028-1034.
    PubMed     Text format     Abstract available


    August 2017
  3. CHARIDIMOU A, Farid K, Baron JC
    Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004539.
    PubMed     Text format     Abstract available


  4. RAPOSO N, Sonnen JA
    Amyloid-PET in cerebral amyloid angiopathy: Detecting vascular amyloid deposits, not just blood.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004548.
    PubMed     Text format    


  5. NEDELSKA Z, Przybelski SA, Lesnick TG, Schwarz CG, et al
    1H-MRS metabolites and rate of beta-amyloid accumulation on serial PET in clinically normal adults.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004421.
    PubMed     Text format     Abstract available


  6. SMITH R, Scholl M, Widner H, van Westen D, et al
    In vivo retention of 18F-AV-1451 in corticobasal syndrome.
    Neurology. 2017;89:845-853.
    PubMed     Text format     Abstract available


    July 2017
  7. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  8. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


    June 2017
  9. BUCKLEY RF, Schultz AP, Hedden T, Papp KV, et al
    Functional network integrity presages cognitive decline in preclinical Alzheimer disease.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004059.
    PubMed     Text format     Abstract available


    May 2017
  10. VANNINI P, Hanseeuw B, Munro CE, Amariglio RE, et al
    Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.
    Neurology. 2017;88:1759-1767.
    PubMed     Text format     Abstract available


    April 2017
  11. LI Y, Kang W, Yang Q, Zhang L, et al
    Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.
    Neurology. 2017;88:1493-1500.
    PubMed     Text format     Abstract available


  12. NG KP, Pascoal TA, Mathotaarachchi S, Chung CO, et al
    Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003916.
    PubMed     Text format     Abstract available


    March 2017
  13. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Text format     Abstract available


  14. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


  15. PAPP KV, Rentz DM, Mormino EC, Schultz AP, et al
    Cued memory decline in biomarker-defined preclinical Alzheimer disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003812.
    PubMed     Text format     Abstract available


    February 2017
  16. CHASSOUX F, Artiges E, Semah F, Laurent A, et al
    18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003714.
    PubMed     Text format     Abstract available


  17. LOCKHART SN, Ayakta N, Winer JR, La Joie R, et al
    Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003724.
    PubMed     Text format    


  18. FRANZMEIER N, Duering M, Weiner M, Dichgans M, et al
    Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003711.
    PubMed     Text format     Abstract available


  19. KREISL WC, Lawrence R, Page E, Teich AF, et al
    11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003693.
    PubMed     Text format    


  20. GROTHE MJ, Villeneuve S, Dyrba M, Bartres-Faz D, et al
    Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.
    Neurology. 2017;88:569-576.
    PubMed     Text format     Abstract available


    January 2017
  21. SPINA S, Schonhaut DR, Boeve BF, Seeley WW, et al
    Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003636.
    PubMed     Text format     Abstract available


  22. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


  23. THOMAS AJ, Attems J, Colloby SJ, O'Brien JT, et al
    Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Neurology. 2017;88:276-283.
    PubMed     Text format     Abstract available


    November 2016
  24. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  25. KIKUCHI A, Okamura N, Hasegawa T, Harada R, et al
    In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Neurology. 2016 Oct 28. pii: 10.1212/WNL.0000000000003375.
    PubMed     Text format     Abstract available


  26. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


    September 2016
  27. MATTSSON N, Zetterberg H, Janelidze S, Insel PS, et al
    Plasma tau in Alzheimer disease.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003246.
    PubMed     Text format     Abstract available


  28. VAUGHAN DN, Rayner G, Tailby C, Jackson GD, et al
    MRI-negative temporal lobe epilepsy: A network disorder of neocortical connectivity.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003289.
    PubMed     Text format     Abstract available


  29. GUROL ME, Becker JA, Fotiadis P, Riley G, et al
    Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.
    Neurology. 2016 Sep 7. pii: 10.1212/WNL.0000000000003197.
    PubMed     Text format     Abstract available


    August 2016
  30. BURNHAM SC, Rowe CC, Baker D, Bush AI, et al
    Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
    Neurology. 2016 Aug 17. pii: 10.1212/WNL.0000000000003094.
    PubMed     Text format     Abstract available


  31. WALKER Z, Moreno E, Thomas A, Inglis F, et al
    Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.
    Neurology. 2016 Aug 10. pii: 10.1212/WNL.0000000000003076.
    PubMed     Text format     Abstract available


    July 2016
  32. CAVALLARO T, Klunk W
    PiB-PET detects transthyretin-related cerebral amyloid angiopathy.
    Neurology. 2016 Jul 27. pii: 10.1212/WNL.0000000000003018.
    PubMed     Text format    


  33. KNOPMAN DS, Jack CR Jr, Wiste HJ, Weigand SD, et al
    Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
    Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002979.
    PubMed     Text format     Abstract available


  34. MORMINO EC, Sperling RA, Holmes AJ, Buckner RL, et al
    Polygenic risk of Alzheimer disease is associated with early- and late-life processes.
    Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002922.
    PubMed     Text format     Abstract available


  35. GOTTESMAN RF, Schneider AL, Zhou Y, Chen X, et al
    The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.
    Neurology. 2016 Jul 1. pii: 10.1212/WNL.0000000000002914.
    PubMed     Text format     Abstract available


    June 2016
  36. CHO H, Choi JY, Hwang MS, Lee JH, et al
    Tau PET in Alzheimer disease and mild cognitive impairment.
    Neurology. 2016 Jun 29. pii: 10.1212/WNL.0000000000002892.
    PubMed     Text format     Abstract available


    May 2016

  37. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2016;86:2116.
    PubMed     Text format    


  38. VASSILAKI M, Aakre JA, Mielke MM, Geda YE, et al
    Multimorbidity and neuroimaging biomarkers among cognitively normal persons.
    Neurology. 2016;86:2077-84.
    PubMed     Text format     Abstract available


  39. WERNER P, Saur D, Mildner T, Moller H, et al
    Combined PET/MRI: Multimodality insights into acute stroke hemodynamics.
    Neurology. 2016;86:1926-7.
    PubMed     Text format    


  40. VOEVODSKAYA O, Sundgren PC, Strandberg O, Zetterberg H, et al
    Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Neurology. 2016;86:1754-61.
    PubMed     Text format     Abstract available


    April 2016
  41. INSEL PS, Mattsson N, Mackin RS, Scholl M, et al
    Accelerating rates of cognitive decline and imaging markers associated with beta-amyloid pathology.
    Neurology. 2016 Apr 15. pii: 10.1212/WNL.0000000000002683.
    PubMed     Text format     Abstract available


    March 2016
  42. LIM YY, Laws SM, Villemagne VL, Pietrzak RH, et al
    Abeta-related memory decline in APOE epsilon4 noncarriers: Implications for Alzheimer disease.
    Neurology. 2016 Mar 30. pii: 10.1212/WNL.0000000000002604.
    PubMed     Text format     Abstract available


  43. LANDAU SM, Horng A, Fero A, Jagust WJ, et al
    Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
    Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576.
    PubMed     Text format     Abstract available


  44. SCOTT G, Ramlackhansingh AF, Edison P, Hellyer P, et al
    Amyloid pathology and axonal injury after brain trauma.
    Neurology. 2016;86:821-8.
    PubMed     Text format     Abstract available


    February 2016
  45. ROUSSAKIS AA, Politis M, Towey D, Piccini P, et al
    Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.
    Neurology. 2016 Feb 26. pii: 10.1212/WNL.0000000000002494.
    PubMed     Text format     Abstract available


  46. VERA JH, Guo Q, Cole JH, Boasso A, et al
    Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.
    Neurology. 2016 Feb 24. pii: 10.1212/WNL.0000000000002485.
    PubMed     Text format     Abstract available


  47. MARNANE M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, et al
    Periventricular hyperintensities are associated with elevated cerebral amyloid.
    Neurology. 2016;86:535-43.
    PubMed     Text format     Abstract available


    January 2016
  48. NERRANT E, Fourcade C, Coulette S, Lechiche C, et al
    Teaching NeuroImages: Extensive vasogenic edema in Bickerstaff brainstem encephalitis.
    Neurology. 2016;86:e38-9.
    PubMed     Text format    


  49. RUSSELL DS, Jennings DL, Barret O, Tamagnan GD, et al
    Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Neurology. 2016 Jan 22. pii: 10.1212/WNL.0000000000002391.
    PubMed     Text format     Abstract available


  50. STOESSL AJ
    Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
    Neurology. 2016;86:228.
    PubMed     Text format    


  51. DEL CAMPO N, Payoux P, Djilali A, Delrieu J, et al
    Relationship of regional brain beta-amyloid to gait speed.
    Neurology. 2016;86:36-43.
    PubMed     Text format     Abstract available


    December 2015
  52. PAYER DE, Guttman M, Kish SJ, Tong J, et al
    D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002285.
    PubMed     Text format     Abstract available


  53. LOHLE M, Mende J, Wolz M, Beuthien-Baumann B, et al
    Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002286.
    PubMed     Text format     Abstract available


    November 2015
  54. CANOSA A, Pagani M, Cistaro A, Montuschi A, et al
    18F-FDG-PET correlates of cognitive impairment in ALS.
    Neurology. 2015 Nov 20. pii: 10.1212/WNL.0000000000002242.
    PubMed     Text format     Abstract available


  55. CHRISTENSEN S, Obi C, Albers G, Lansberg M, et al
    Ultra-acute CT perfusion imaging: A stroke in the scanner.
    Neurology. 2015;85:1725-6.
    PubMed     Text format    


    September 2015
  56. LEE DH, Oh JS, Ham JH, Lee JJ, et al
    Is normosmic Parkinson disease a unique clinical phenotype?
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001999.
    PubMed     Text format     Abstract available


    July 2015
  57. BREITNER JC
    Yet another "disconnect" between amyloid and Alzheimer disease?
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001871.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: